Long Covid continues to afflict patients and mystify clinicians. The National Institutes of Health is trying to identify potential treatments and it is launching a series of clinical trials that will assess a wide range of therapeutic interventions.
Bond-Smith has provided a short list of industries with potential to “make use of uniquely Hawaiʻi capabilities and are appropriate for our small scale.”
The findings illustrate the important impact that the trillions of bacteria in our gut collectively called our 'gut microbiome' have on our immune health and add a missing piece to the puzzle of why vaccination varies in effectiveness from person to person